Mediastinal nodal involvement in patients with clinical Stage I non-small-cell lung cancer: possibility of rational lymph node dissection

Tomohiro Haruki, Keiju Aokage, Tomohiro Miyoshi, Tomoyuki Hishida, Genichiro Ishii, Junji Yoshida, Masahiro Tsuboi, Hiroshige Nakamura, Kanji Nagai

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: The aim of this study is to elucidate the optimal candidate of selective lymph node dissection (LND) that reduces the extent of mediastinal LND according to clinical information including radiological evaluation in primary non-small-cell lung cancer (NSCLC) patients. Methods: Eight hundred and seventy-six patients with clinical(c)-stage I NSCLC (adenocarcinoma and squamous cell carcinoma), who underwent complete surgical resection between January 2003 and December 2009 were included in this study. We elucidated the lymph node metastatic incidence and distribution according to the primary tumor lobe location and extracted the associated clinicopathological factors, especially thin-section computed tomographic findings, with mediastinal lymph node involvement. Results: The total incidence of mediastinal lymph node metastasis was 9.1%. There were no cases with hilar and mediastinal lymph node metastasis in ground glass opacity-predominant tumors. There was no significant association of clinical factors with subcarinal lymph node metastasis in right upper-lobe and left upper-division adenocarcinoma. An elevated preoperative serum carcinoembryonic antigen level (p < 0.001) showed significant associations with upper mediastinal lymph node metastasis in the patients with bilateral lower-lobe primary lung adenocarcinoma. Conclusions: It would be acceptable to perform selective LND in patients with c-stage I NSCLC with ground glass opacity- predominant tumor. Elevated serum carcinoembryonic antigen was associated with upper mediastinal lymph node involvement in lower-lobe primary lung adenocarcinoma with radiologically solid-predominant tumor. We should be careful when applying selective LND to patients with solid-predominant tumor, especially located in the lower lobe.

Original languageEnglish
Pages (from-to)930-936
Number of pages7
JournalJournal of Thoracic Oncology
Volume10
Issue number6
DOIs
Publication statusPublished - 2015 Jun 30
Externally publishedYes

Fingerprint

Lymph Node Excision
Non-Small Cell Lung Carcinoma
Lymph Nodes
Neoplasm Metastasis
Carcinoembryonic Antigen
Neoplasms
Glass
Incidence
Serum
Squamous Cell Carcinoma
Adenocarcinoma
Adenocarcinoma of lung

Keywords

  • Consolidation-to-tumor ratio
  • Mediastinal lymph node metastasis
  • Non-small-cell lung cancer
  • Selective lymph node dissection
  • Solid-predominant

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this

Mediastinal nodal involvement in patients with clinical Stage I non-small-cell lung cancer : possibility of rational lymph node dissection. / Haruki, Tomohiro; Aokage, Keiju; Miyoshi, Tomohiro; Hishida, Tomoyuki; Ishii, Genichiro; Yoshida, Junji; Tsuboi, Masahiro; Nakamura, Hiroshige; Nagai, Kanji.

In: Journal of Thoracic Oncology, Vol. 10, No. 6, 30.06.2015, p. 930-936.

Research output: Contribution to journalArticle

Haruki, Tomohiro ; Aokage, Keiju ; Miyoshi, Tomohiro ; Hishida, Tomoyuki ; Ishii, Genichiro ; Yoshida, Junji ; Tsuboi, Masahiro ; Nakamura, Hiroshige ; Nagai, Kanji. / Mediastinal nodal involvement in patients with clinical Stage I non-small-cell lung cancer : possibility of rational lymph node dissection. In: Journal of Thoracic Oncology. 2015 ; Vol. 10, No. 6. pp. 930-936.
@article{4c8ba16e16fc4d27a9c6152bee3275f2,
title = "Mediastinal nodal involvement in patients with clinical Stage I non-small-cell lung cancer: possibility of rational lymph node dissection",
abstract = "Background: The aim of this study is to elucidate the optimal candidate of selective lymph node dissection (LND) that reduces the extent of mediastinal LND according to clinical information including radiological evaluation in primary non-small-cell lung cancer (NSCLC) patients. Methods: Eight hundred and seventy-six patients with clinical(c)-stage I NSCLC (adenocarcinoma and squamous cell carcinoma), who underwent complete surgical resection between January 2003 and December 2009 were included in this study. We elucidated the lymph node metastatic incidence and distribution according to the primary tumor lobe location and extracted the associated clinicopathological factors, especially thin-section computed tomographic findings, with mediastinal lymph node involvement. Results: The total incidence of mediastinal lymph node metastasis was 9.1{\%}. There were no cases with hilar and mediastinal lymph node metastasis in ground glass opacity-predominant tumors. There was no significant association of clinical factors with subcarinal lymph node metastasis in right upper-lobe and left upper-division adenocarcinoma. An elevated preoperative serum carcinoembryonic antigen level (p < 0.001) showed significant associations with upper mediastinal lymph node metastasis in the patients with bilateral lower-lobe primary lung adenocarcinoma. Conclusions: It would be acceptable to perform selective LND in patients with c-stage I NSCLC with ground glass opacity- predominant tumor. Elevated serum carcinoembryonic antigen was associated with upper mediastinal lymph node involvement in lower-lobe primary lung adenocarcinoma with radiologically solid-predominant tumor. We should be careful when applying selective LND to patients with solid-predominant tumor, especially located in the lower lobe.",
keywords = "Consolidation-to-tumor ratio, Mediastinal lymph node metastasis, Non-small-cell lung cancer, Selective lymph node dissection, Solid-predominant",
author = "Tomohiro Haruki and Keiju Aokage and Tomohiro Miyoshi and Tomoyuki Hishida and Genichiro Ishii and Junji Yoshida and Masahiro Tsuboi and Hiroshige Nakamura and Kanji Nagai",
year = "2015",
month = "6",
day = "30",
doi = "10.1097/JTO.0000000000000546",
language = "English",
volume = "10",
pages = "930--936",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "6",

}

TY - JOUR

T1 - Mediastinal nodal involvement in patients with clinical Stage I non-small-cell lung cancer

T2 - possibility of rational lymph node dissection

AU - Haruki, Tomohiro

AU - Aokage, Keiju

AU - Miyoshi, Tomohiro

AU - Hishida, Tomoyuki

AU - Ishii, Genichiro

AU - Yoshida, Junji

AU - Tsuboi, Masahiro

AU - Nakamura, Hiroshige

AU - Nagai, Kanji

PY - 2015/6/30

Y1 - 2015/6/30

N2 - Background: The aim of this study is to elucidate the optimal candidate of selective lymph node dissection (LND) that reduces the extent of mediastinal LND according to clinical information including radiological evaluation in primary non-small-cell lung cancer (NSCLC) patients. Methods: Eight hundred and seventy-six patients with clinical(c)-stage I NSCLC (adenocarcinoma and squamous cell carcinoma), who underwent complete surgical resection between January 2003 and December 2009 were included in this study. We elucidated the lymph node metastatic incidence and distribution according to the primary tumor lobe location and extracted the associated clinicopathological factors, especially thin-section computed tomographic findings, with mediastinal lymph node involvement. Results: The total incidence of mediastinal lymph node metastasis was 9.1%. There were no cases with hilar and mediastinal lymph node metastasis in ground glass opacity-predominant tumors. There was no significant association of clinical factors with subcarinal lymph node metastasis in right upper-lobe and left upper-division adenocarcinoma. An elevated preoperative serum carcinoembryonic antigen level (p < 0.001) showed significant associations with upper mediastinal lymph node metastasis in the patients with bilateral lower-lobe primary lung adenocarcinoma. Conclusions: It would be acceptable to perform selective LND in patients with c-stage I NSCLC with ground glass opacity- predominant tumor. Elevated serum carcinoembryonic antigen was associated with upper mediastinal lymph node involvement in lower-lobe primary lung adenocarcinoma with radiologically solid-predominant tumor. We should be careful when applying selective LND to patients with solid-predominant tumor, especially located in the lower lobe.

AB - Background: The aim of this study is to elucidate the optimal candidate of selective lymph node dissection (LND) that reduces the extent of mediastinal LND according to clinical information including radiological evaluation in primary non-small-cell lung cancer (NSCLC) patients. Methods: Eight hundred and seventy-six patients with clinical(c)-stage I NSCLC (adenocarcinoma and squamous cell carcinoma), who underwent complete surgical resection between January 2003 and December 2009 were included in this study. We elucidated the lymph node metastatic incidence and distribution according to the primary tumor lobe location and extracted the associated clinicopathological factors, especially thin-section computed tomographic findings, with mediastinal lymph node involvement. Results: The total incidence of mediastinal lymph node metastasis was 9.1%. There were no cases with hilar and mediastinal lymph node metastasis in ground glass opacity-predominant tumors. There was no significant association of clinical factors with subcarinal lymph node metastasis in right upper-lobe and left upper-division adenocarcinoma. An elevated preoperative serum carcinoembryonic antigen level (p < 0.001) showed significant associations with upper mediastinal lymph node metastasis in the patients with bilateral lower-lobe primary lung adenocarcinoma. Conclusions: It would be acceptable to perform selective LND in patients with c-stage I NSCLC with ground glass opacity- predominant tumor. Elevated serum carcinoembryonic antigen was associated with upper mediastinal lymph node involvement in lower-lobe primary lung adenocarcinoma with radiologically solid-predominant tumor. We should be careful when applying selective LND to patients with solid-predominant tumor, especially located in the lower lobe.

KW - Consolidation-to-tumor ratio

KW - Mediastinal lymph node metastasis

KW - Non-small-cell lung cancer

KW - Selective lymph node dissection

KW - Solid-predominant

UR - http://www.scopus.com/inward/record.url?scp=84938268976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938268976&partnerID=8YFLogxK

U2 - 10.1097/JTO.0000000000000546

DO - 10.1097/JTO.0000000000000546

M3 - Article

C2 - 26001143

AN - SCOPUS:84938268976

VL - 10

SP - 930

EP - 936

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 6

ER -